PEPSICO, INC for PEPSICO INC
What was lobbied
13 issue areas, each in the filer's own words, with who lobbied on it and where.
Financial Institutions/Investments/Securities FIN
Corporate governance issues (generally, no specific legislation); Monitoring regulatory proposals at the Securities and Exchange Commission relating to the disclosure of political activities by corporations (generally, no specific proposed rules).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BOYKAS | — |
Disaster Planning/Emergencies DIS
Issues related to implementation of the CARES Act, H.R. 748. Issues related to implementation of the first emergency supplemental appropriations bill to respond to COVID 19. Issues related to implementation of the Families First Coronavirus Response Act, PL 116-127.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BOYKAS | — |
| DAN CHRISTENSON | — |
| SARAH TOWLES | — |
Agriculture AGR
Issues related to commodity procurement of orange juice at the U.S. Department of Agriculture (generally, no specific legislation); Issues related to Dietary Guidelines for Americans (development of 2020 guidelines by U.S. Department of Agriculture and U.S. Department of Health and Human Services); Issues related to implementation of the Farm Bill (P.L.115-334, the Agriculture Improvement Act of 2018), including provisions relation to nutrition (Supplemental Nutrition Assistance Program; Reauthorization of the Farm Bill (S. 954, Agriculture Reform, Food, and Jobs Act of 2013; H.R. 2642 Federal Agriculture Reform and Risk Management Act of 2013; H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013; H.R. 3102, Nutrition Reform and Work Opportunity Act of 2013), including provisions relating to commodities, biotechnology, nutrition (Supplemental Nutrition Assistance Program), mandatory country-of-origin labeling, and citrus trust fund; Issues related to harmonizing USDA and FDA nutrition facts panel requirements (generally, no specific legislation); Implementation of the Agricultural Act of 2014, including provisions relating to commodities, nutrition (Supplemental Nutrition Assistance Program), and biotechnology.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BOYKAS | — |
| DAN CHRISTENSON | — |
Trade (domestic/foreign) TRD
Issues related to tariffs and trade sanctions, generally, and in regard to the Presidential Proclamations on steel and aluminum imports, and the related Department of Commerce interim rule at 83 Fed. Reg. 12106; Issues related to US-Mexico-Canada Agreement (generally, no specific provisions); US-China Section 301 provisions related to tariffs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BOYKAS | — |
| SARAH TOWLES | — |
Trucking/Shipping TRU
Issues related to Commercial Driver's License (CDL) truck driver shortages (generally, and S.569 DRIVE-Safe Act, H.R.1374 DRIVE-Safe Act); Issues related to extension of expiring Commercial Drivers Licenses and Medical Certificate renewals due to COVID National Emergency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BOYKAS | — |
| DAN CHRISTENSON | — |
| SARAH TOWLES | — |
Commodities (big ticket) CDT
Issues related to the Midwest Premium Price for aluminum (generally, and H.R. 1406, the APEX Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH TOWLES | — |
Transportation TRA
Issues related to increasing the gross vehicle weight (GVW) limit for interstate trucks (generally, no specific legislation); Issues related to delivery of nutritious meals to children and families affected by COVID (generally, no specific legislation); Issues relating to Hours of Service of Drivers; H.R. 4745/ S. 2438, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BOYKAS | — |
| DAN CHRISTENSON | — |
| SARAH TOWLES | — |
Food Industry (safety, labeling, etc.) FOO
Issues related to Supplemental Nutrition Assistance Program (SNAP) purchasing restrictions, generally and with regard to the Agriculture and Nutrition Act of 2018 (H.R.2); Issues related to implementation of the Bioengineered Food Disclosures Act (P.L. 114-214), and the National Bioengineered Food Disclosure Standard proposed rule at Fed.Reg.19860; Issues related to health and wellness, including obesity prevention and fitness (generally, no specific legislation); Issues related to food labeling challenges caused by COVID-19 (generally, no specific legislation); Issues related to food supply chain disruptions caused by COVID-19 (generally, no specific legislation); Issues related to implementation of the Food Safety Modernization Act, generally, and Intentional Adulteration implementing regulations (generally, no specific provisions); Issues relating to child nutrition, generally and with regard to the implementation of the Healthy, Hunger-Free Kids Act of 2010 (Local School Wellness Policy; Nutrition Standards for All Foods Sold in School); Issues relating to nutrition (H.R. 1303, School Nutrition Flexibility Act; H.R. 1752, SNAP Transparency Act of 2013; H.R. 1783, School Food Modernization Act; H.R. 1503, No Hungry Kids Act; H.R. 1500, Nutrition Education Act; H.R. 1395, Weekends Without Hunger Act; H.R. 1355 State Nutrition Assistance Flexibility Act of 2013; H.R. 1303, School Nutrition Flexibility Act; H.R. 1244, Sensible School Lunch Act; H.R. 428, School Meals Reimbursement Rates Comparison Act of 2013; 7 CFR Part 272, Nutrition Education and Obesity Prevention Grant Program; Summer Food Service Program); Revision of the Nutrition and Supplement Facts Labels (FDA Proposed Rule); Issues relating to energy drinks (generally, no specific legislation); Food and nutrition labeling (generally, and with regards to H.R.1699, Genetically Engineered Food Right-to-know Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BOYKAS | — |
| DAN CHRISTENSON | — |
| SARAH TOWLES | — |
Environment/Superfund ENV
Issues related to packaging and recycling (generally, no specific legislation).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BOYKAS | — |
| DAN CHRISTENSON | — |
Medical/Disease Research/Clinical Labs MED
Issues relating to noncommunicable diseases (generally, no specific legislation).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BOYKAS | — |
Advertising ADV
Issues relating to marketing and advertising (generally, no specific legislation).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BOYKAS | — |
Manufacturing MAN
Issues related to manufacturing plant safety and worker safety during COVID-19 (generally, no specific legislation).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BOYKAS | — |
| DAN CHRISTENSON | — |
| SARAH TOWLES | — |
Economics/Economic Development ECN
Issues related to workforce development (generally, no specific legislation).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BOYKAS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.